This Article Full Text Full Text (PDF) All Versions of this Article: bjo.2007.134429v1 92/5/655    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Google Scholar Articles by Lipski, A Articles by Jurklies, B PubMed PubMed Citation Articles by Lipski, A Articles by Jurklies, B Topic Collections Editor's choice Relevant Article

Photodynamic therapy with verteporfin in paediatric and young adult patients: long-term treatment results of choroidal neovascularisations

Department of Ophthalmology, University Hospital Essen, Essen, Germany

Correspondence to:
Dr A Lipski, Department of Ophthalmology, Universitätsklinikum Essen, Hufelandstraße 55, D-45122 Essen, Germany; andreas.lipski{at}uni-duisburg-essen.de

Background: Vision impairment in children and young adults may derive from choroidal neovascularisation (CNV) related to numerous conditions. The aim of this study is to highlight the applicability of photodynamic therapy using verteporfin (PDT) in these patients.

Methods: In 16 eyes of 16 consecutive patients aged 30 years or younger, prospective open-label PDT was performed. Outcomes of visual acuity as well as changes in CNV lesion parameters were evaluated.

Results: The mean patient age at first PDT was 19.7 (SD 8.7) years (range 6–30). 81% of the patients retained stable vision within two lines or exceedingly improved vision during follow-up of 34 (24) months. Significant vision gain was denoted in seven paediatric patients (2.7 (1.4) lines, mean (SD); p = 0.019) as well as in a subgroup of 12 patients not affected by active uveitis (2.6 (2.0) lines, p = 0.0005). Two patients with multifocal choroiditis and panuveitis (MCP) experienced vision losses of five and 11 lines after four PDT sessions despite receiving additional steroidal treatment. Except for one patient with MCP and two patients who dismissed follow-up, a mean of 2.2 (1.3) PDTs per patient sufficiently inactivated CNV lesions during follow-up. In the area of the former PDT spot, alterations of the pigment epithelium increased by 40% without correlation to changes in vision.

Conclusions: The results indicate good PDT efficacy and tolerability most promising in a subgroup of patients with vision-impairing CNV not associated with active uveitis. PDT in young patients with CNV remains a valuable treatment with good risk–benefit profile over the long term.

Competing interests: None.

Ethics approval: The design of the study was reviewed by the authors and the institutional review board. All procedures were in full accordance with local ethics board requirements.

Relevant Article

At a glance

Harminder S Dua and Arun D Singh
Br. J. Ophthalmol. 2008 92: 585. [Extract] [Full Text] [PDF]